English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16844/19259 (87%)
Visitors : 7160577      Online Users : 582
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/22204


    標題: Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-κB signaling pathway.
    作者: Po-Lin Kuo
    Ya-Ling Hsu
    Ta-Chen Lin
    Wen-Sheng Tzeng
    Yin-Yi Chen
    Chun-Ching Lin
    貢獻者: 生物科技系
    關鍵字: Rugosin E
    Breast cancer
    Apoptosis
    Cell cycle
    NF-κB
    日期: 2007-04
    上傳時間: 2010-01-12 09:13:11 (UTC+8)
    摘要: In this study, we first report the chemopreventive effect of rugosin E in human breast cancer cell line, MDA-MB-231. Treatment with rugosin E decreased the cell proliferation of MDA-MB-231 cells in a dose-dependent manner. Rugosin E treatment arrested MDA-MB-231 cells at G0/G1 phase. This effect was strongly associated with concomitant decrease in the level of cyclin D1, cyclin D2, cyclin E, cdk2, cdk4, and cdk6, and increase of p21/WAF1. In addition, rugosin E also induced apoptotic cell death. Rugosin E increased in the expression of Bax, Bak, and Bcl-Xs, but decreased the levels of Bcl-2 and Bcl-XL, and subsequently triggered mitochondria apoptotic pathway (release of cytochrome c, activation of caspase-9, and caspase-3). In addition, pre-treatment of cells with caspase-9 inhibitor blocked rugosin E-induced cell proliferation and apoptosis, indicating caspase-9 activation was involved in rugosin E-mediated MDA-MB-231 cells apoptosis. Rugosin E inhibited the constitutively activated and inducible NF-κB in both its DNA-binding activity and transcriptional activity. Furthermore, rugosin E also inhibited the TNF-α-activated NF-κB-dependent reporter gene expression of cyclin D1, c-Myc, XIAP, Bcl-2, and Bcl-XL were all downregulated by rugosin E. Our results indicated that rugosin E inhibits the activation of NF-κB, and this may provide a molecular basis for drug development in the prevention and treatment of cancer by rugosin E.
    Appears in Collections:[生物科技系(所)] 期刊論文

    Files in This Item:

    File SizeFormat
    0KbUnknown660View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback